Cardiology

Study finds no net benefit from common anti-clotting drug

A costly drug frequently used to treat patients with heart disease may offer no greater benefit than standard medications, say Yale researchers. Their study calls into question widespread use of the drug bivalirudin (Angiomax) ...

Oncology & Cancer

Novel PET tracer narrows in on life-threatening blood clots

Fatal cardiac events are often preceded by abnormal blood clots, also called thrombosis. Scientists have now developed a molecular imaging technique that could save lives by revealing troublesome thrombi, according to a study ...

Cardiology

Review: Short vs. long duration dual antiplatelet Tx after stent

(HealthDay)—Dual antiplatelet therapy (DAPT) continued beyond six months after drug-eluting stent implantation is associated with reduced stent thrombosis and myocardial infarction but also increased bleeding and all-cause ...

Cardiology

Cutting edge research and collegiality the focus of EuroPCR 2015

Technique, talk, and talent were three buzzwords at the 2015 EuroPCR congress. As in years past, the conference featured a mix of breaking news, live case demonstrations, oral and poster sessions, debates, and tips-and-tricks ...

page 19 from 40